Lynn M. Russo, Ph.D.,is an associate in Hughes Hubbard & Reed's Intellectual Property practice. She has extensive experience in preparation and prosecution of patent applications, as well as in litigation and arbitration.
Lynn also has experience in invalidity and non-infringement opinions, due diligence, portfolio management and client counseling in areas including:
next-generation sequencing technologies
cancer biology/immunology/vaccine/stem cell research
industrial processes and plants/foods and food supplements
Prior to joining Hughes Hubbard, Lynn worked at both large general practice and intellectual property boutique law firms. During Lynn's graduate studies, she identified and characterized novel genes involved in nervous system development and neurodegeneration.
"IP and COVID-19," Pharmaceutical Executive (March 11, 2021)
"Impacts of COVID-19 on Intellectual Property in Multiple Jurisdictions: United States" International Bar Association (July 2020)